Cancer is one of the leading causes of morbidity and mortality in Malaysia and worldwide. According to the Health Ministry’s Malaysia National Cancer Registry Report 2012–2016 released in 2020,  people with lung and liver cancers had a five-year relative survival rate of only 11 and 12.8 percent, respectively.

On top of that, more people are being diagnosed late with cancer. The percentage of breast cancer cases detected in Stage 3 and 4 rose from 43.2 percent in the period of 2007 - 2011 to 47.9 percent in the period of 2012 to 2016.


This worrying trend is also similar for other common cancers like lung cancer, colorectal cancer, prostate cancer and uterine cervix cancer, where more patients are presenting at advanced late stage 4 disease.

When cancer care is delayed, there is a lower chance of survival, greater problems associated with treatment and higher costs of care. Early diagnosis improves cancer outcomes by providing care at the earliest possible stage and is therefore an important public health strategy in all settings.


In this interview, Dr Aminudin Rahman bin Mohd Mydin, Consultant Clinical & Radiation Oncologist at KPJ Damansara Specialist Hospital would be sharing his insights on early detection and prevention of cancer, new developments in cancer treatments and KPJ’s state of the art Elekta Versa HD Linear Accelerator radiotherapy system.

Malaysia’s homegrown KPJ Healthcare Berhad is the leading provider of private healthcare services in the country with an integrated network of more than 28 specialist hospitals located throughout the nation. The healthcare provider has five (5) Centre of Excellence for Cancer Care located at KPJ Damansara Specialist Hospital, KPJ Ampang Puteri Specialist Hospital, KPJ Johor Specialist Hospital and KPJ Ipoh Specialist Hospital.

test